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INTRODUCTION
Pancreatic pseudocysts are encapsulated collections of necrotic tissue, 
old blood and secretions from the pancreas.  The prefix “pseudo” is used to 
emphasize the fact that these collections frequently have no true capsule and 
that the cyst wall is made up of adjacent viscera such as the stomach and / or 
colon.
The  pseudocysts  are  the  most  common  complications  following 
pancreatic inflammation both acute and chronic. They also constitute the most 
frequently encountered cystic lesions of the pancreas others being the cystic 
neoplasms.
The pseudocysts present clinically as epigastric pain, abdominal masses 
to jaundice. The laboratory findings are not much of use in the diagnosis of 
these  pseudocysts.  It  is  radiology  which  helps  in  the  diagnosis  of  the 
pseudocysts with the help of USG, CT scan, MRI, etc. These investigations 
govern the therapeutic procedures to be carried out.
The treatment team for pseudocysts includes radiologists, endoscopists 
and surgeons. The radiologists by way of guided per-cutaneous techniques for 
aspiration/drainage to the therapeutic embolization of bleeding aneurysms and 
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the endoscopists by way of various endoscopic drainage procedures contribute 
to the team.
The surgeon plays an important and definitive role in the therapeutic 
team with an array of techniques both open and laproscopically. It is ultimately 
to provide adequate,  dependent drainage of pseudocyst  contents  before they 
present with any complications.
This study is carried out to analyze the various etiological factors that 
lead on to the formation of pancreatic pseudocysts. The various diagnostic and 
therapeutic  procedures  available  for  intervention  are  also  studied  and  their 
indications  and  contra-indications  with  their  advantages  compared  in  this 
series.
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DESCRIPTIOIN
PANCREATIC PSEUDOCYSTS
Pancreatic pseudocyst is a localized collection of pancreatic secretions, 
surrounded by a wall of fibrous or granulation tissue, which arises as a result of 
• Pancreatic inflammation
• Pancreatic trauma
• Obstruction of pancreatic duct by a neoplasm.
Pseudocysts comprise about 75% of cystic lesions of pancreas. They are 
distinguished  from  other  fluid  collections  (cystic  neoplasms,  congenital, 
parasitic and extrapancreatic cysts) by
• Lack of epithelial lining
• High concentration of pancreatic enzymes within the pseudocysts
• Formation  at  least  4  weeks  after  an  episode  of  pancreaitis  / 
trauma.
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TERMINOLOGY
As pseudocysts may resemble other collections of fluids that may arise 
as a complication of acute pancreatitis,  clear definitions are to be laid. The 
present  consensus  on  these  has  been  prescribed  in  “The  International 
Symposium on Acute Pancreatitis” held in 1992 at Atlanta.
Acute fluid collections:
• Form early in the course of early pancreatitis.
• Lack a discrete wall of fibrous/granulation tissue.
• Occur in 30 to 50% of cases.
• Most regress spontaneously without directed therapy or drainage.
• Most do not represent communication with the pancreatic duct.
Pancreatic Pseudocyst:
• Fluid collection persisting -> 4 weeks.
• Usually surrounded by a well defined wall
• May/may not communicate with the pancreatic ductal system.
Pancreatic Abscess:
• Circumscribed  collection  of  purulent  infected  fluid  containing 
little or no necrotic material.
• Complication of acute pancreatitis or trauma.
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• Occurs late in the course of severe acute pancreatitis, often 4 or 
more weeks after the onset of symptoms.
ETIOLOGY
Pancreatic psuedocycts occur in 5-10% patients with acute pancreatitis. 
With  improved  imaging  technique,  the  prevalence  of  asymptomatic 
pseudocysts has been improved. Pseudocysts are believed to occur in 10-20% 
patients  with  acute  pancreatitis  and  in  20-40%  patients  with  chronic 
pancreatitis.
Pseudocysts occur more commonly in males than in females, a finding 
that perhaps reflects the frequent occurrence of these patients with alcoholic 
pancreatitis.  Alcohol appears to be the cause of  65% of pancreatitis  related 
pseudocysts and gall stones for the origin of the other 15% of the cases.
Trauma in both forms blunt and penetrating can result in psuedocycts 
formation. In adults, trauma as an etiological factor is seen in around 15-20% 
of pseudocysts while in children they are the most common cause of pancreatic 
psuedocyts seen in around 60%.
Patholophysiology
The backgrounds for formation of pseudocyst are mainly three.
(a) Acute pancreatitis.
(b) Chronic pancreatitis.
(c) Abdominal trauma.
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The  processes  by  which  pseudocysts  are  formed  depend  on  these 
factors.
(i) Acute Pancreatitis.  
Pseudocysts occurring in the setting of acute inflammatory episodes are 
called “Acute Pancreatic Pseudocysts”. They occur after acute pancreatitis of 
any etiology including acute flares of chronic pancreatitis. 
Richter  has  elegantly  summarized  the  pathogenesis  of  pseudocyst 
formation.  In  an  acute  attack  of  pancreatitis,  there  is  direct  leakage  of 
pancreatic juice from the inflamed area of the gland, which accumulates in a 
space adjacent 
to the pancreas. Ductular disruption is secondary to pancreatic necrosis, even 
though the attack need not be clinically severe. Since, there is no natural barrier 
to the dissection this fluid, either cephalad or caudad in the retro peritoneum. 
Acute pseudocyst may locate anywhere in the mediastinum to the scrotum.
The most common site of accumulation of the leaking pancreatic juice is 
the potential space of the lesser omentum (lesser sac) limited anteriorly by the 
stomach, inferiorly by the transverse mesocolon, laterally by the spleen and by 
the  splenic  flexure  on the left  and the duodenum on the  right.  The evoked 
inflammatory response induces the formation of a distinct cyst wall composed 
of granulation tissue and blood vessels, which organizes with more connective 
tissue  and  fibrosis.  The  cyst  cavity  contains  enzymatic  fluid  and  necrotic 
debris.
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Observations  supporting the  concept  that,  at  it’s  origin,  a  pseudocyst 
must have had a communication with the pancreatic duct are as follows:
• The  amylase  levels  of  the  aspirated  cystic  fluid  is  many  times 
greater than the simultaneous serum levels
• Per cutaneous drainage of pseudocysts results in a prolonged period 
of drainage indicating a communicating fistula
• Radiologic studies,  such as  contrast  injection into the  pseudocyst 
and ERCP, have clearly demonstated such a communication in two 
thirds of patients. With time, however, the communication may or 
may not persist because the inflammatory reaction that follows cyst 
formation may occlude the fistula.
The algorithm in the formation of acute pancreatitis is as follows.
Pancreatic Inflammation
Diffuse peripancreatic effusions
Pancreatic Necrosis
Liquefaction
Swelling (phlegmon)
Acute pseudocyst
Encapsulation
12
Maturation
(ii) Chronic Pancreatitis  
“Chronic  Pancreatic  Pseudocysts”  are  those  that  are  formed  in  the 
background  of  chronic  pancreatic  inflammations.  While  acute  flare-ups  of 
chronic pancreatitis results in pseudocyst through steps as mentioned earlier, in 
chronic pancreatitis,  the initiating event is duct rupture owing to inspissated 
proteins, stones or strictures with subsequent blow-out of the pancreatic ducts.
As the pancreatic parenchyma is firm and fibrotic, chronic pseudocysts 
are  commonly  located  within  the  substance  of  the  gland.  The  chronic 
pseudocyst  is  virtually  impossible  to  distinguish  clinically  from  pancreatic 
retention cyst which are formed by progressive dilation of a pancreatic duct 
distal to an obstruction and also rise in the setting of chronic pancreatitis. The 
only  differentiating  feature  remains  the  presence  of  epithelial  lining  in  the 
retention  cysts.  In  chronic  pancreatitis,  pseudocysts  are  more  often  seen  in 
those with minimal fibrosis than in those with advanced fibrosis and calculi.
(iii) Pancreatic Trauma  
“Traumatic  Pancreatic  Pseudocysts”  are  caused  by  duct  disruption 
secondary to blunt trauma. The duct is  usually  injured where it  crosses the 
vertebral column and therefore these cysts tend to occur interior of the body of 
the gland.
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PATHOLOGY
Macroscopy:
Pseudocysts  can  be  single  or  multiple.  Most  cysts  (90%)  are  single. 
Multiple pseudocysts are more often seen in acute alcoholic pancreatitis. The 
size varies from 2 to 30 cms with estimated volumes reported between 50 and 
6000ml. Small pseudocysts are often located within the pancreas, with nearly 
one third located in the head and two thirds in the body and the tail. They are 
often located outside the pancreas in the lesser sac, where they extend to the 
adjacent viscera. Extension into transverse mesocolon may occur because of 
the anatomic relationship of transverse colon to the pancreas. The cysts may 
also  extend  to  the  anterior  or  posterior  para  renal  space,  mediastinum and 
retroperitoneum.
Posterior  pseudocysts,  although  rare,  may  extend  inferiorly  into  the 
pelvic region and groin, and pseudocysts extending to the scrotum have been 
encountered. The cysts are often smooth and rounded. Thick granulation tissue 
separates the cysts from the surrounding structures.
The cyst contents have been well studied. The fluid may be clear and 
watery or xanthochromic or brown because of old blood and necrotic tissue. 
The amylase, lipase and trypsin contents are usually markedly elevated, and it 
is exceptional to find amylase activity lower than serum levels.
The amylase level may decrease in some pseudocysts in existence for a 
long time. It is hypothesized that the cyst may have lost it’s communication 
with the ductal system coupled with the possibility that the fluid in the cyst 
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exchanges  with  the  plasma.  The  aforementioned  mechanism  also  explains 
spontaneous disappearance of small pseudocysts.
Microscopy:
The cyst wall characteristically is composed of granulation and 
fibrous tissue without an epithelial lining. In an acute pseudocyst, usually four 
zones can be distinguished in the wall. 
Zone 1 - Hemosiderin pigment and loose connective tissue 
Zone 2 - Inflammatory cells and capillary-rich fibrous tissue 
Zone 3 - Hyalinized acellular connective tissue 
Zone 4 - Capillary-rich fibrous stroma.
The pseudocyst wall is a dynamic structure associated with a series of 
continuous biologic changes. The histology of the wall varies according to the 
age of the pseudocyst. Older cysts have thicker walls with increased collagen, 
fibronectin  and  smooth  muscle  content.  The  histologic  appearance  is 
independent  of  the  cause  with  no  differences  in  the  structure  of  the  walls 
between alcoholic and biliary pancreatitis and idiopathic pancreatitis. 
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CLASSIFICATION
Modern  imaging  techniques,  including  USG,  CT  and  ERCP  have 
provided  a  clear  understanding  of  the  different  types  of  fluid  collections 
associated with pancreatitis and have led to a working classification to assist in 
the timing and choice of treatment. A classification put forward by D’Egido 
and Schein is:-
Features Type I a Type I b Type II
1. Antecedent
2. Loaction
3. Site
4. Cyst Wall
5. Content
6. Colour
7. Duct
communication
8. Risk of 
Sepsis
Post Necrotic
Extra-pancreatic
Lesser Sac
Immature/Mature
Necrotic/Liquefied
Pus like/black
~30%
High
Acute on chronic
Mostly extra-pancreatic
Lesser Sac
Immature/mature
Pancreatic Juice
Clear/Prune
~60%
Moderate/Low
Chronic
Intra-pancreatic
Head
Mature
Panreatic juice
Clear
100%
Low
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CLINICAL PRESENTATION
Abdominal pain: 
According to  Crass and Becker,  epigastric  pain is  the most  common 
symptom in  patients  with  a  pseudocyst.  It  occurs  in  upto  90% of  patients. 
Pseudocysts that follow an episode of acute pancreatitis are often characterized 
by the persistence or recurrence of upper abdominal pain weeks after the initial 
attack.
A pseudocyst may also be the source of increased or refractory pain in a 
patient known to have chronic pancreatitis.
The other common symptoms include:
• Nausea and vomiting (50-70%)
• Weight loss (20-50%)
• Abdominal Fullness (40%)
• Jaundice (10%)
• Low Grade fever (10%)
• Early satiety
The symptoms of early satiety, nausea and vomiting may be secondary 
due to mass effect of the pseudocyst that causes gastro-duodenal obstruction. 
Obstructive  jaundice  due  to  extraneous  biliary  tree  compression  may  be 
presenting complaint in 10% of patients.
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Rarely,  patients  with  pseudocysts  may  not  present  until  a  secondary 
complication occurs. These complications include
• Sepsis secondary to infection
• Hypovolemic shock secondary to pseudocyst – associate 
hemorrhage.
• Jaundice secondary to CBD obstruction
• Severe acute abdominal pain secondary to intra-peritoneal 
rupture of pseudocyst.
Patients with pseudocyst secondary to trauma may present with similar 
symptoms,  at  a  time remote  from the trauma.  So they  are  likely to  have a 
mature wall at diagnosis.
Physical Findings:
The sensitivity of physical examination findings is limited.
Patients very frequently have a tender abdomen.
Patients occasionally have a palpable mass in the abdomen. The absence 
of a mass does not exclude the diagnosis of pseudocysts, even large ones can 
be hidden by the coastal margins
Peritoneal signs suggest rupture of the cyst or infection.
Other possible findings include the following:
• Fever
• Scleral icterus
• Pleural effusion
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DIAGNOSIS
Laboratory Parameters
No  laboratory  findings  are  available  to  establish  a  diagnosis  of 
pancreatic pseudocyst. Elevated serum amylase and lipase concentrations may 
occur  in  half  these  patients.  In  fact,  a  persistently  elevated  amylase,  after 
resolution of acute pancreatitis should prompt investigation for a pseudocyst. 
Aspirated pseudocyst fluid may be useful to differentiate between the various 
pancreatic cystic lesions. 
A few parameters which are useful to this are:-
Types of 
Cystic Lesions
Viscosity CEA CA
125
CA
15-3
CA
72-4
Amylase Cytology
1.Pseudocyst
2.Serous 
Cystadenoma
3. Benign 
mucinous 
cystic 
neoplasms
4.Mucinous 
Cystadeno 
carcinoma
Low
Low
Usually 
High
High
Low
Low
High
High
Low
Low
Low
High
Low
Low
Low
High
Low
Low
Low
High
High
Variable
Variable
Variable
Negative
Negative
Usually 
positive
Usually 
positive
A few patients with a pseudocyst have mild leucocytosis, whereas others 
have elevated liver function tests, indicative of some biliary tree obstruction.
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Radiological Investigations
USG: It  is  a simple non-invasive investigating modality which helps in the 
diagnosis of pancreatic pseudocysts. Hessel et al. found ultrasound to be 90% 
accurate and 98% specific  in the diagnosis  of  pseudocysts  but the pancreas 
could not be visualized because of bowel gas or other technical problems in 
one-third of their patients. The usefulness of ultrasound as an initial diagnostic 
test  is  also limited  by  its  inability  to  provide crucial  information  regarding 
adjacent structures, maturity of cyst wall and retro-peritoneal extension of the 
fluid collection. It still is an excellent modality for diagnosis and following the 
progress of the course of pseudocysts as it is less costly and does not expose 
the patient to ionizing radiation. 
Abdominal CT scan: CT scan is the standard imaging criterion for pancreatic 
pseudocysts. It has a sensitivity of 90 -100% and is not operator dependent.
The usual finding on CT scan is a large cyst cavity in and around the pancreas.
Multiple  cysts  may be  present.  The  pancreas  may appear  irregular  or  have 
calcifications.  Pseudoaneurysms  of  the  splenic  artery,  bleeding  into  a 
pseudocyst,  biliary and enteric obstruction,  and other complications may be 
noted on CT scan. The CT scan provides a very good appreciation of the wall 
thickness of the pseudocyst, which is useful in planning therapy.
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ULTRASOUND - PANCREATIC PSEUDOCYST
CT – PANCREATIC PSEUDOCYST
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MRI:  MRI is not necessary for the diagnosis of pseudocysts; however, it is 
useful in detecting a solid component to the cyst and in differentiating between 
organized  necrosis  and  a  pseudocyst.  A  solid  component  makes  catheter 
drainage difficult; therefore, in the setting of acute necrotizing pancreatitis with 
resultant pseudocyst, an MRI may be very important before a planned catheter 
drainage procedure.
Conventional MRI also has the potential  advantage of being coupled 
with magnetic resonance, cholangio-pancreaticography (MRCP) to help define 
pancreatic ductal anatomy relative to a pseudocyst. 
ERCP: It demonstrates abnormalities of the pancreatic duct in upto 90% of the 
patients with pseudocysts. Nearly two-thirds of pseudocysts communicate with 
the pancreatic duct.  Obstructions of the pancreatic duct,  compression of the 
duct by the cyst or changes consistent with chronic pancreatitis are frequently 
noted. It can help define the anatomic relationship between the cyst and the 
pancreatic duct and plan the extent of anastamosis or resection before surgery.
ERCP  is  an  invasive  procedure  that  potentially  could  aggravate 
pancreatitis  or  introduce  infection  into  the  pseudocyst  in  spite  of  the 
prophylactic  antibiotics.  Thus,  it  is  proposed  that  if  ERCP  is  to  be  used, 
especially in patients with large pseudocysts, it should be performed within 24-
48 hours of a planned drainage procedure.
Endoscopic ultrasound (EUS):  It is not necessary for diagnosis but is very 
important  in  planning  therapy,  particularly  if  endoscopic  drainage  is 
contemplated.
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A gastric  wall  with a thickness greater than 1 cm next to the cyst tends to 
predict a poor outcome with endoscopic drainage. EUS may also be helpful in 
detecting small portal collaterals from otherwise undetected portal hypertension 
that may increase bleeding risks with transmural drainage. Transmural drainage 
may be performed only when the symptomatic pseudocyst is positioned next to 
the gut wall. 
Pseudocysts appear as anechoic, fluid-filled structures adjacent to the 
UGI tract and the pancreas. Fluid collections associated with acute pancreatitis 
will not be surrounded with a well-defined wall, whereas a thick, hyperechoic 
rind  often  surrounds  pseudocysts.  Calcifications  within  the  wall  are  rare. 
Within  the  pseudocyst  cavity  is  fluid  without  air.  Debris  in  the  dependent 
portion of the cavity is common and may represent blood, infection, or necrotic 
material.  Color  Doppler  of  the  wall  will  often  reveal  multiple,  prominent 
vessels,  including  para-gastric  varices.  Evaluation  of  suspected  pseudocysts 
with  EUS  prior  to  drainage  is  important  for  confirming  the  diagnosis, 
determining  the  precise  location,  and  determining  the  thickness  of  the 
pseudocyst wall. Catheter probe endosonography can also be used to localize 
pseudocysts.
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EUS – PANCREATIC PSEUDOCYST
Arteriography:  It  is  generally  not  useful  for  diagnosis  of  pseudocysts  nor 
should it be necessary in the pre-operative evaluation of pseudocysts. However, 
in patients who have had bleeding complications from pseudocyst or those who 
have portal hypertension, it may provide valuable information that can alter the 
surgical approach. The finding of splenic vein thrombosis with left sided portal 
hypertension is an indication of splenectomy in patients undergoing operation 
for drainage of pseudocysts. 
24
MANAGEMENT
The management options available for pancreatic pseudocyst are:-
• Observation
• Percutaneous aspiration / drainage
• Endoscopic procedures
• Operative approaches (open/ laparoscopy)
 Internal drainage
 External Drainage
 Resection
Conservative
More than 50% of patients can be expected to require no interventions 
except observations with regular follow-ups. To qualify for conservative, non-
operative  management,  patients  should  have  no  symptoms  referable  to  the 
pseudocyst,  no  pseudocyst  related  complications  and a  stable  or  decreasing 
pseudocyst size. 
The medical treatment of acute pseudocyst is essentially that of acute 
pancreatitis, including parenteral nutrition to minimize stimulation of pancreas. 
Pancreas  secretory suppression with somatostatin  has been beneficial  in  the 
treatment of pancreatic ascites and in theory should encourage the healing and 
resolution pseudocysts  by reducing secretions which fills  the cysts.  Patients 
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who do not meet any of these criteria at follow-up evaluation should undergo 
appropriate intervention.
Percutaneous aspiration/Drainage 
Percutaneous aspiration is aimed at aspirating all pseudocyst fluid at one 
procedure without leaving indwelling catheter drainage. It has not been widely 
used as a definitive procedure as the risk of recurrence is particularly high due 
to persistent communication with the pancreatic duct. However, this method 
can  be  utilized  as  a  therapeutic  procedure  in  pseudocysts  where  sepsis  is 
suspected or for rapidly expanding collections to avoid the risk of ruptures, and 
in type I-b collections, when no pancreatic duct leak has been demonstrated on 
ERCP.
Percutaneous  catheter  drainage  involves  placement  of  an  indwelling 
catheter  into  a  pseudocyst  by  the  Seldinger  technique  using  USG  or  CT 
guidance. The pseudocyst is normally entered through a flank or transgastric 
approach and the tract may be dilated to accept a catheter ranging in size from 
no.7 to no.14 French. These catheters are typically irrigated or flushed with 
small amounts of saline two or three times a day to ensure patency and they are 
left to drain by gravity drainage to an attached bag.  
Contra indications through percutaneous drainage include the presence 
of significant pancreatic necrosis or solid debris in the pseudocyst, lack of safe 
access  route,  pseudocyst  hemorrhage  and complete  obstruction  of  the  main 
pancreatic duct. Complications associated with the procedure are infection of 
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the  drain tract,  persistent  or recurrent  pseudocyst  and pancreatico-cutaneous 
fistula. 
USG GUIDED ASPIRATION
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Endoscopic procedures 
The endoscopic techniques used for drainage of pseudocyst include:-
• Transpapillary cyst drainage (TCD)
• Transmural endoscopic cyto-gastrostomy (TECG)
• Endoscopic cysto duodenostomy.
Transpapillary  drainage:  While  safer  and  more  effective  than  transmural 
drainage, this technique requires cyst communication with the pancreatic duct. 
This technique may be technically challenging because it requires wire passage 
and stenting through the pancreatic duct to the pseudocyst. The success rate is 
about  80%.  The  recurrence  rate  is  10-14%,  and,  in  most  series,  the 
complication rate  (mainly  pancreatitis)  is  approximately 13%. It  is  possible 
when a communication exists between the pancreatic duct and the pseudocyst, 
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it is ideal in cases of associated proximal duct obstruction that is closed to the 
papilla. Technically demanding TDC required advancing a co-axial guide wire 
system beyond the strictures or stones and placing the stent either into the cyst 
or beyond the site of the leak. 
Transmural pseudocyst Drainage:  Most widely used endoscopic technique 
for  drainage.  Only  pseudocysts  involving  the  pancreatic  head  or  body  are 
suitable for endoscopic procedure. The distance between the pseudocyst cavity 
and the gastric or duodenal lumen must be less than 10mm as measured by CT 
or endoscopic USG.
The technique of transmural drainage is similar for endoscopic cysto-
duodenostomy and cysto-gastrostomy. A side viewing scope is used to identify 
the site of maximal bulge and a needle knife is used to make a small diathermy 
incision to enter the pseudocyst. The catheter is then advanced into the cavity 
through the puncture site to facilitate the subsequent placement of the stent. 
The choice  of  cyst  drainage either  into  the  stomach or  duodenum is 
determined  by  the  area  where  the  bulge  into  the  bowel  lumen  is  most 
prominent. The duodenum is usually preferred as its mucosa and duodenal wall 
is generally thinner and less risk is seen of bleeding from sub-mucosal vessels.
This method has an 82-89% success rate in very experienced hands. The 
recurrent rate is 6-18%. The complication rate is 20%, with the most feared 
complication being bleeding. 
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SURGICAL PROCEDURES
Internal Drainage: The  preferred  approach  for  most  uncomplicated 
pseudocysts  requiring surgical  intervention is  internal  drainage.  Mature cyst 
can  be  drained  into  the  stomach,  duodenum  or  small  bowel.  The  surgical 
procedure is chosen depending on the location of the pseudocyst and the local 
topography. 
(1)  Cystogastrostomy
Cyst  adherent  to  stomach is  ideally  drained by a  cysto  gastrostomy. 
After ascertaining that the cyst is firmly adherent to the stomach, an anterior 
gastrotomy is  made.  Pseudocyst  confirmed by aspiration and an incision as 
long as possible is made through the posterior gastric wall into the pseudocyst. 
A small ellipse of common posterior gastric and cyst wall is excised and sent 
for frozen section examination to exclude neoplasia. Septations within cyst are 
broken  down  and  haemostasis  along  cut  edges  is  achieved  with  closely 
interrupted  non-absorbable  sutures  to  approximate  the  gastric  wall  and  the 
pseudocyst. 
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(2) Cystoduodenostomy
Procedure similar to cysto gastrostomy and is used for pseudocysts in 
the pancreatic head or uncinate process that lie within 1cm of duodenal lumen.
(3) Cystojejunostomy
Most versatile technique of operative drainage and is appropriate when a 
pseudocyst is located at the base of transverse mesocolon and is not adherent to 
posterior gastric wall. One important difference from other procedure is that 
this is a double layered anastamosis. 
External Drainage
Indicated when gross infection is found at the time of operation or when 
an immature, thin walled pseudocyst is encountered that will not allow for safe 
internal  drainage.  The  contents  of  pseudocyst  cavity  are  then  completely 
evacuated and at least one closed suction drain is placed into the cavity and is 
brought out through the abdominal wall. Appropriate antibiotic therapy should 
be instituted and follow up CT / USG obtained to ensure that the pseudocyst is 
entirely drained. 
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CYSTO DUODENOSTOMY
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Resections
 
A  small  proportion  of  pseudo  cysts  are  best  treated  by  pancreatic 
resections. More commonly this operation involves distal pancreatectomy for 
pseudocysts located  in  the  body  (or  the  tail  of  the  gland). After distal 
pancreatectomy  a  Roux  –  en  –  Y  pancreatiocojejunostomy  to  the  remnant 
pancreas may be required to decompress an obstructed or abnormal pancreatic 
duct.  In  a  few  patients  with  symptomatic  pseudocysts  in  the  head  of  the 
pancreas,  associated  with  an  inflammatory  mass,  excisional  therapy  may 
require  pancreaticoduodenectomy.  In  this  case,  pylorus  preserving 
pancreaticoduodenectomy is the procedure of choice. 
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COMPLICATIONS
 Bleeding is the most feared complication and is caused by the erosion of 
the pseudocyst into a vessel. Consider the possibility of bleeding in any 
patient who has a sudden increase in abdominal pain coupled with a 
drop in hematocrit level or a change in vital signs. Therapy is emergent 
surgery or angiography with embolization of the bleeding vessel. Do not 
perform a  percutaneous  or  endoscopic  drainage  procedure  under  any 
circumstances in patients with suspected bleeding into a pseudocyst.
 Consider the possibility of infection of the pseudocyst in patients who 
develop  fever  or  an  elevated  WBC  count.  Treat  infection  with 
antibiotics and urgent drainage.
 GI obstruction, manifesting as nausea and vomiting, is an indication for 
drainage.
 The pseudocyst can also rupture. A controlled rupture into an enteric 
organ occasionally causes GI bleeding. On rare occasions, a profound 
rupture into the peritoneal cavity causes peritonitis and death.
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REVIEW OF LITERATURE
In 1979, Bradley et al followed acute fluid collections in pancreatitits by 
ultrasonogram and suggested that cysts  present for  less than 6 weeks had a 
40 % spontaneous resolution rate, whereas those which were present for longer 
almost never resolved (Am. J Surg. 137 : 135, 1997 )
Experimental  studies  by  Warren  et  al  first  suggested  that  it  takes  6 
weeks for  the formation of  a mature cyst  wall,  and this  figure  has become 
accepted as a guideline.
According  to  Crass  and  Becker,  epigastric  pain  is  the  presenting 
complaint in   90 % patients with pancreatic pseudocysts. Nausea and vomiting 
were present in nearly half of the patients and weight loss was present in 40%. 
As many as 60 % of patients had an epigastric mass and fever.  Jaundice may 
also be part of the examination. (Am. Jour. Surg. 1984; 142: 660).
Warshaw and Rattner have reported that appearance in the pseudo cyst 
and in the blood stream of an amylase isoamylase (old amylase) is a reliable 
marker of cyst wall maturity.
Levandrowski  and colleagues  evaluated  the  intracystic  fluid  from 26 
cystic lesions for amylase content,  cytology, relative viscosity and serologic 
markers CEA and CA- 125. He found elevated levels of amylase in pseudocyst 
fluid while CEA and CA-125 were absent in them (Ann. Surg. 1983; 217:41)
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Hessel found ultrasound to be 90 % accurate and 98 % specific when the 
pancreas could be visualized. Unfortunately, gas shadows obscure the pancreas 
in nearly one third of the patients.
Ahearne et  al  in a 1992 study has suggested that  those pseudo cysts 
which have communication with the duct as shown by ERCP should be treated 
with surgical drainage or resection, whereas those which do not communicate 
may be drained per cutaneously. (Am. Journ. Surg. 1992; 163:111)
 Gullo  and  Barbara  used  somatostatin  as  the  primary  therapy  for 
pseudocysts.  They  treated  seven  patients  with  pseudocysts  with  octreotide 
(100mg three  times a  day for  2  weeks).  Four  of  the  seven demonstrated  a 
decrease  in  size.  More  significantly,  there  was  a  definite  decrease  in  the 
intensity of pain. (Lancet 338:540-541, 1991).  
In  1997,  Gouyton  et  al,  reviewed  90  patients  with  pseudocysts  and 
found that cyst size > 4 cm, cyst enlargement and extra pancreatic involvement 
were independent predictive factors for non resolution and complications of 
pseudocysts.
A recent series published by Yeo et al indicated that cyst size is the 
primary determinant of the success of expectant treatment. In this series, 75 
patients  were  observed,  with  surgery  being  reserved  for  those  with  cyst 
enlargement,  abdominal  pain  and  complication.  Of  this  group,  48  %  were 
managed expectantly,  whereas 52% required surgery. When the two groups 
were compared, the only significant difference was that of cyst size ( 7.4 + 0.6 
cm  versus 5.8 + 0.8 cm ) . (Curr. Prob. Surg. 31: 165, 1994)
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Boettger et al in a series of 145 patients who were internally drained, 
reported a recurrence rate of 10 % He stressed the importance of anastamosis 
sufficiency that  is  at least  3 to 4 cms in diameter.  Otherwise,  recurrence is 
possible because of the premature closure of a small anastamosis between the 
cyst cavity and the stomach or intestinal limb.
One study attempted to determine which factors could predict successful 
pseudocyst with percutaneous aspiration. Patients with pseudocysts in the tail 
of the pancreas, with pseudocysts with total volumes less than 100ml and with 
low  intracystic  amylase  levels  appeared  to  be  the  best  candidates  for  per 
cutaneous aspiration according to this study of 67 patients.
After  62 per  cutaneous drainage procedures done in 42 patients  with 
pseudo  cysts,  Cradio  et  al  reported  33  treatment  failures  (i.e.  persistent  or 
recurrent pseudo cyst) during a mean follow up of 10 months. (Surg. Obstet. 
Gynaec.1992; 175:293)
A few reports on per cutaneous drainage of non- infected pseudocysts:
Author Cases 
(n)
Drainage 
duration 
(days)
Compln. Fistula Success 
(%)
Follow 
up
(months)
Matzinger et al 12 11-47 0 0 100 ns
Van sonnenberg et al 50 17 ns 6 66 8-48
Grosso et al 42 ns 2 0 67 27
D’Egidio & Schein 23 11-47 1 0 67 ns
Adams & Anderson 52 42 5 1 81 ns
ns – Not Significant
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Lo  and  Rowe  in  their  review  of  the  endoscopic  management  of 
pancreatic pseudo cysts found a 16% recurrence rate, 20% complication rate 
and 17% of the patients needed an additional non endoscopic, mostly surgical 
intervention. (Gastroenterologist 1997; 5:10)
In 1997, Berckingham et al reported a 62 % long term success rate of 
endoscopic internal drainage. In their series, patients who had a wall fusion 
thickness  of  <  1  cm  and  whose  cysts  were  bulging  into  the  stomach  and 
duodenum  were  shown  to  be  ideally  suited  for  endoscopic  treatment  (Br.  
Journ. Surg. 1997; 84:1638)
Weckman reported an approximately 86% success rate with endoscopic 
drainage with a 10% complication rate and a 14% failure rate. There appeared 
to be about a 15% recurrence rate. There was no real difference in outcome in 
patients treated with a transpapillary or transmural approach.
The  only  prospective  study  comparing  per  cutaneous  and  operative 
interventions in comparable patients to date has been by Lang and colleagues. 
In  this  study,  patients  were  alternately  assigned  to  either  per  cutaneous  or 
operative drainage. Both procedures have similar rates of success with 88 % of 
pseudocysts ablated by operative management and 77 % through per cutaneous 
drainage. (South Med. Journ. 1991; 84:55)
A  study  by  Berrns  et  al,  showed  a  42  %  success  rate  treating 
pseudocysts by per cutaneous drainage compared with an 88 % success rate for 
those treated with surgical internal drainage. He also reported a significantly 
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higher  complication  rate  with  per  cutaneous  drainage  when  contrasted  to 
surgical drainage (64 % versus 27%)
Newell et al comparing cystojejunostomy with cystogastrostomy found 
similar post operative morbidity, mortality and recurrence rates but noted that 
cystogastrostomy was performed more quickly and with less blood loss.
Though cystogastrostomy has been advocated by many authors because 
of  its  technical  advantages,  Johnson  et  al  reported  life  threatening  post 
operative  complications  and  2  deaths,  in  patients  with  large  pseudocysts 
(> 15 cm) who were treated with the procedure.  These complications  were 
attributed to incomplete emptying of the pseudocysts, a finding emphasizing 
that complete dependent drainage is critical in any internal drainage procedure 
and solid materials lining a pseudocysts should be thoroughly debrided   at the 
time of internal drainage.
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AIMS OF THE STUDY 
 To understand the epidemiology of pancreatic pseudocysts.
 To analyze the various treatment modalities that can be utilized in the 
management of the pancreatic pseudocysts
 To  try  USG  guided  aspiration  technique  as  a  primary  modality  of 
treatment  in  pancreatic  pseudocysts  before  other  therapeutic 
interventions.
 To  compare  USG  guided  per-cutaneous  aspiration  with  the  other 
treatment options available in terms of patient and physician factors.
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MATERIAL AND METHODS
Place of Study : Madras Medical College and Government 
Hospital, Chennai.
Period of Study : Aug 2003 to March 2006.
Type of Study : Prospective
Selection Criteria : Patients were selected with symptomatic 
pseudocysts from the Department of General 
Surgery, GGH.
The patients included in the study were to satisfy the following criteria:-
 Prior consent to be obtained.
 Pseudocysts with greater than or equal to 6 weeks duration were 
involved in the study.
No. of patients studied : 40
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Methods:
The  selected  patients  were  subjected  to  a  detailed  history  elicitation 
followed by thorough evaluation of risk factors and clinical features.
They were  then subjected with baseline investigations  (Biochemistry, 
Haemogram,  and  Chest  Skiagram).  This  was  then  followed  up  by  specific 
investigations like serum amylase, liver function tests, USG – Abdomen and 
CT – Abdomen.
Each patient was individualized and treated accordingly. The outcomes 
were documented. 
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OBSERVATIONS AND RESULTS
A total  of 40 patients  with symptomatic pancreatic pseudocysts  were 
included in this series. All subjects satisfied the inclusion criteria. The results 
obtained from the study can be discussed as follows.
Sex:
Among the 40 patients, 7 patients were females and the remaining 33 
males.
Total Male Female
40 33
(82.5%)
7
(17.5%)
Sex
Male
Female
Age Groups:
The subjects were mostly in the 3rd to 4th decade of life.
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Age No. of patients Percentage %
10-20
21-30
31-40
41-50
51-60
61-70
5
10
14
7
3
1
12.5
25
45
22.5
7.5
2.5
0
2
4
6
8
10
12
14
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Age
10-20
21-30
31-40
41-40
51-60
61-70
Clinical Features:
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The clinical presentations of the patients were pain abdomen, nausea , 
vomiting, loss of appetite, mass abdomen and jaundice. Among these, loss of 
appetite was the predominant symptom followed by pain abdomen.
Clinical Feature No. of patients Percentage %
Pain Abdomen
Nausea / vomiting
Mass Abdomen
Jaundice
Loss of appetite
31
24
15
3
36
77.5
60
37.5
7.5
90
0 10 20 30 40
No. of Patients
Clinical
Feature
Pain Abdomen Nausea/Vomiting
Mass Abdomen Jaundice
Loss of Appetite
Clinical Background:
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Pancreatic pseudocysts in the setting of acute pancreatitis were found in 
32 of the patients. Chronic pancreatic pseudocysts were found in just 2 of the 
subjects. Trauma was the etiological agent in the remaining 6 patients.
Clinical Background
Acute 
Pancreatitis
80%
Chronic 
Pancreatitis
5%
Trauma
15%
Acute Pancreatitis Chronic Pancreatitis
Trauma
Among  the  patients  with  acute  pancreatic  inflammation,  alcohol 
contributes to the majority of cases accounting for 27 of the 32 patients. In 4 
patients, etiology for acute pancreatitis could not able to be elucidated. Only 1 
case of gallstone pancreatitis was encountered.
Physical Findings:
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The three clinical features which were studied were:
 Tenderness
 Mass Abdomen
 Jaundice
The results are tabulated as below:
Physical Findings No. of Patients Percentage %
Mass
Tenderness
Jaundice
25
36
3
62.5%
90%
7.5%
Mass
Tenderne
ss
Jaundice
0
5
10
15
20
25
30
35
40
Physical Findings
Physical findings
Mass
Tenderness
Jaundice
Lab Findings:
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Only two parameters, namely serum amylase and liver functions were 
studied in this series.
Serum  amylase  showed  normal  values  in  14  subjects  and  in  the 
remaining subjects showed mild to moderate levels of increase.
Liver function tests were elevated in only 5 of the subjects (12.5%).
USG / CT Findings:
Location:
The study showed that lesser sac is the most common site for pancreatic 
pseudocysts in 20 of 40 subjects (50%). The head, body and tail of the pancreas 
was found to be the locations in 2, 4 and 14 subjects respectively.
Location No. of Patients Percentage %
L.S. 20 50
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Head 
Body
Tail
2
4
14
5
10
35
Location
LS
HeadBody
Tail
LS
Head
Body
Tail
Size:
The longest diameter of the pseudocyst was taken into account.
Size No. of Patients Percentage %
3 – 6
7 – 9
10 – 12
27
7
6
67.5
17.5
1.5
Treatment:
Three treatment modalities were studied in this series. They were:
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a) Conservative
b) USG guided percutaneous technique
c) Surgical procedures
Nine patients showed resolution of pseudocysts by conservative line of 
management.  15 patients  were  treated by percutaneous techniques  while  16 
patients were taken up for surgical intervention.
Surgery Per-cutaneous drainage Conservative
16 15 9
0
2
4
6
8
10
12
14
16
Management
Surgery
Per-cutaneous
drainage
Conservative
Conservative Management:
Among the 9 patients who were treated expectantly, 8 patients had acute 
pseudocysts and remaining 1 patient had a psuedocyst subsequent to trauma. 
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Young  patients  were  found  to  be  responding  better  to  expectant  line  of 
management. 
The pseudocysts showed resolution in 7 days – 15 days with a mean of 
10.5 days. During this period, patients were placed on antibiotics. Serial USG 
was used for follow-up every 5 days.
Serum amylase was elevated in 8 of the 9 patients. Serum liver function 
tests were normal in all patients.
The size of the cysts which showed resolution to the expectant line of 
management were found to be 5cm and less in maximum diameter with the 
exception  of  one  psuedocyst  of  size  6cm  which  resolved  spontaneously. 
Pseudocysts in the tail and lesser sac which were 4 in number each resolved by 
expectant  line  of  management  while  only  1  pseudocyst  in  the  body  of  the 
pancreas resolved spontaneously.
USG guided aspiration / Technique:
A total of 18 patients were subjected in this study. Of them 3 were found 
to be infected and were subjected to surgical intervention by external drainage.
Among the 18 patients, 1 patient had acute pseudocysts. Remaining 4 
pseudocysts were found in the background of blunt trauma. Patients with pain 
who were taken up for aspiration had good improvements in their symptoms.
Among the 15 patients who were totally managed with USG guided per-
cutaneous technique, 7 patients had pseudocysts in the tail, 6 in the lesser sac 
and 1 each in the body and head of the pancreas.
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Size of the pseudocysts was an important factor determining the success 
of this treatment modality.
Size (in cms.) No. of patients
2.1 – 3
3.1 – 4
4.1 – 5
5.1 - 6
6
5
3
1
In  addition  to  size,  the  volume  of  fluid  aspirated  is  the  next  factor 
determining the success of management.
Volume of fluid 
aspirated (ml)
No. of patients
50 – 60
61 – 70
71 – 80
81 – 90
5
6
4
1
50-60
61-70
71-80
81-90
0
1
2
3
4
5
6
Volume (ml)
Volume of Fluid aspirated
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Among the  15 cysts,  3  pseudocysts  had to  undergo repeat aspiration 
while 2 among those required repeated aspirations which were subjected to per-
cutaneous catheter drainage. These two catheters were maintained for 7 and 9 
days. The algorithm of patients treated by this technique is as shown below.
USG GUIDED PERCUTANEOUS DRAINAGE
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Total number
(18)
USG guided Aspiration
Resolved Completely
(10)
Infected Pseudocysts
(3)
Recurrence
(5)
Surgical Intervention Reaspiration
Resolved
(3)
Recurrence
(2)
Percutaneous 
catheter 
drainage
Surgery:
A total of 16 subjects had to be intervened surgically. 11 cases of acute 
pseudocysts,  3  case  of  chronic  pseudocysts  and  2  cases  of  traumatic 
pseudocysts were encountered.
11
3
2
Acute
Chronic
Post-traumatic 
The various locations of pseudocysts that were managed surgically are 
depicted below:
Location No. of patients
Lesser Sac
Tail
Body
Head
10
3
2
1
55
The pseudocyst size with greater than or equal to 6cm were the ones 
which were taken for surgical intervention.
Among the surgical procedures, external drainage was performed in 3 
cases, resections in 2 and internal drainage in 11 cases. Of internal drainage, 
cystogastrostomy was done in 9, cysto-jejunostomy and cysto-duodenostomy 
in 1 case each. It is the location of the pseudocyst which governs the drainage 
procedure.
0
2
4
6
8
10
12
Procedures
External Drainage Cystogastrostomy
Cysto-jejunostomy Cysto-duodenostomy
Resection
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SURGERY
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Pseudocysts for Surgical 
Intervention
(16)
Head
(1)
Body
(2)
Tail
(3)
Cysto 
Duodenostomy
(1)
Cysto 
Gastrostomy
(1)
Cysto 
Jejunostomy
(2)
Cysto 
Jejunostomy
(1)
Cysto 
Gastrostomy
(1)
Cysto 
Gastrostomy
(7)
Internal 
Drainage
(7)
Lesser Sac
(10)
Infected Pseudocyst
(3)
External 
Drainage
(3)
CONCLUSION
The study conducted on these forty patients of pancreatic pseudocysts 
has revealed the following data:
Pancreatic  pseudocysts  are  a  fairly  common  complication  of 
pancreatitis.  Only 2 cases  of  chronic  pancreatitis  were  encountered.  6  were 
post-traumatic and the remaining was found to be acute pancreatitis.
Alcohol leads the way in the etiological factor for pancreatitis and its 
pseudocyst complication.
Pseudocysts are commonly encountered in third to fourth decade of life. 
A  majority  of  them  were  following  inflammatory  etiology.  Traumatic 
pseudocysts were found in the second decade of life in our study.
Males dominated the series, confirming the etiological background of 
alcohol leading to pancreatitis. (4.55:1)
Epigastric  pain was the common clinical  presentation seen in 77.5%. 
Loss  of  appetite  was  an  invariable  feature  in  a  good  majority  of  patients. 
Abdominal mass and jaundice were reported by a few patients.
USG – Abdomen and CT – Abdomen were both useful in the diagnosis. 
CT scan was better used for diagnostic purposes and USG served as the tool of 
follow-up in this series.
About  50%  of  pseudocysts  were  located  in  the  lesser  sac  with  the 
distribution in head, body and tail being 5, 10 and 35 percentage respectively.
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While  nine  pseudocysts  were  treated  and  resolved  by  conservative 
means, thirty-one had to be intervened. Of those pseudocysts which resolved, 
they were less than or equal to 5cm and were involving the lesser sac (or)  
pancreatic tail.
USG – Abdomen in addition to diagnosis has shown in this study 
to be a good therapeutic option for aspiration. Fifteen pseudocysts resolved by 
per-cutaneous drainage techniques either aspiration (13) or catheter drainage 
(2). Aspiration alone has proved to be an effective therapeutic option in centers 
where ERCP is  not used for  diagnosis.  A good number of  patients  showed 
resolution especially relief of pain by this technique.
Among  surgical  techniques,  cystogastrostomy  was  the  most 
widely  used  technique.  Except  for  three  infected  pseudocysts,  no  other 
complications were encountered. The series had zero mortality. 
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